Tag: #Global Trends

Key Development Gilead Sciences and the Pan American Health Organization have established a new pathway to broaden access to twice-yearly... Read more

Key Development Roughly five months after its U.S. launch, Eli Lilly's Foundayo (orforglipron) has captured more than 30% of new... Read more

Key Development Abbott Laboratories has agreed to pay $384,999,040 to resolve False Claims Act allegations involving powdered infant formula and... Read more

Key Development Ori Biotech has entered into a 10-year strategic collaboration with an undisclosed biopharmaceutical company, with the agreement valued... Read more

Key Development Testosterone use among U.S. women is rising rapidly, particularly among menopausal women experiencing persistently low sexual desire. A... Read more

Key Development Definium Therapeutics has delivered another positive Phase 3 result for DT120 ODT, its fast-dissolving lysergide, or LSD, therapy... Read more

Key Development Novo Nordisk is adopting “Novo” as its everyday corporate name while introducing a new cultural framework, “The Novo... Read more

Key Development On September 14, 2026, the U.S. FDA convened a four-hour public hearing examining how psychedelic medicines could eventually... Read more

Key Development BioNTech and OncoC4 have reported updated survival data for gotistobart (BNT316/ONC-392) in patients with metastatic squamous non-small cell... Read more